Jury finds Parse willfully infringed Scale Biosciences' patents and rejects Parse's invalidity challenge
3 Small-Cap Stocks with Open Questions
5 Revealing Analyst Questions From 10x Genomics’s Q2 Earnings Call
1 High-Flying Stock to Own for Decades and 2 We Question
TXG Q2 Deep Dive: Atera Launch Signals Transition as Spatial Market Shifts
1 Unpopular Stock That Deserves Some Love and 2 That Underwhelm
10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations
Barchart Research What to Expect from TXG Earnings TXG Generated August 5, 2026 Current Price $47.46 EPS Estimate $$-0.23 Consensus Rating Moderate Buy Average Move 4.94% 10x Genomics Launches Atara Platform...
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect